Loading clinical trials...
Loading clinical trials...
Our main hypothesis is that EPC function is impaired in some populations with high cardiovascular risk as a result of reduced eNOS-dependent NO production.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, San Francisco
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT05841784 · Cardiovascular Diseases
NCT05516277 · Posttraumatic Stress Disorder, Insomnia, and more
NCT04971720 · Obesity, Cardiovascular Diseases, and more
NCT06675552 · Heart Disease, Heart Failure, and more
UCSF, Department of Cardiology
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions